The director of IVOQA presented advances in the use of organoids and was elected as a member of the scientific society’s Board of Directors
Brazil hosted the fifth congress of the International Society for the Study of Pleura and Peritoneum (ISSPP), an event that brought together specialists from around the world to share the latest advances in the approach to peritoneal pathology.
During the congress, Dr. Delia Cortés Guiral, director of IVOQA (Instituto Viamed de Oncología Quirúrgica Avanzada / Viamed Institute of Advanced Surgical Oncology), was invited to give a presentation on the use of organoids in oncology. In her presentation, she explained how culturing organoids from the patients’ own tumors allows for a personalized evaluation of the response to various treatments—both intravenous and intraperitoneal—before they are administered, paving the way for increasingly precise therapeutic strategies tailored to each individual case.
The day before the start of the congress, the first PIPAC training course organized in Brazil was also held. During this session, specialists from Brazil, Ecuador, and other Latin American countries received specific training in this technique from four international instructors: Olivia Gargiulo, Martin Hübner, Mohamed Alyami, and Dr. Delia Cortés Guiral herself.
Over the course of the three scientific days, the latest evidence and advances in the treatment of peritoneal metastases were reviewed, including strategies such as PIPAC, NIPS, and HIPEC, which are helping to expand the therapeutic options available to these patients.
Furthermore, during the society’s general assembly, the new Board of Directors of the ISSPP was elected. Dr. Delia Cortés Guiral will be a part of this board—a recognition of her scientific career and her contribution to the international development of peritoneal oncology.
